5-Methyl-6,7-dihydro-5H-cyclopenta[b]pyrazine
Common Name: |
5-Methyl-6,7-dihydro-5H-cyclopenta[b]pyrazine |
IUPAC Name: |
5-methyl-6,7-dihydro-5H-cyclopenta[b]pyrazine |
Molecular Formula: |
C7H8N2O |
SMILES: |
CC1CCC2=NC=CN=C12 |
Inchi: |
1S/C8H10N2/c1-6-2-3-7-8(6)10-5-4-9-7/h4-6H,2-3H2,1H3 |
Inchi Key: |
YZEFQPIMXZVPKP-UHFFFAOYSA-N |
Cas No: |
23747-48-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
136.15 |
Mass (g/mol) |
134.084 |
Molar Refractivity |
37.19 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
1 |
Rings |
2 |
TPSA |
42.85 |
Hetero Atoms |
2 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
121.00 to 123.00 @ 1.00 mm Hg |
Boiling Point (°C@760.00mm Hg) |
200.00 to 201.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.291 |
Vapor Density (Air =1) |
4.6 |
Fraction Csp3 |
0.29 |
LogP |
1.526 |
iLOGP |
1.50 |
XLOGP3 |
0.20 |
WLOGP |
0.99 |
MLOGP |
-0.75 |
ESOL Log S |
-1.19 |
ESOL Solubility (mg/ml) |
8.83 |
ESOL Solubility (mol/l) |
0.065 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-0.66 |
Ali Solubility (mg/ml) |
29.9 |
Ali Solubility (mol/l) |
0.22 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.34 |
Silicos-IT Solubility (mg/ml) |
0.62 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.99 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.759 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.008 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |